首页> 外国专利> MARKERS, METHOD FOR INSPECTION, AND INSPECTION KIT FOR MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER, AND METHOD FOR SCREENING THERAPEUTIC MEDICINES FOR MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER

MARKERS, METHOD FOR INSPECTION, AND INSPECTION KIT FOR MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER, AND METHOD FOR SCREENING THERAPEUTIC MEDICINES FOR MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER

机译:主要抑郁障碍和双歧疾病的标志物,检查方法和检查工具包,以及针对重大抑郁障碍和双歧疾病的治疗药物的筛选方法

摘要

PROBLEM TO BE SOLVED: To provide markers, a method for inspection, and an inspection kit for a major depressive disorder and a bipolar disorder, and a method for screening therapeutic medicines for a major depressive disorder and a bipolar disorder.;SOLUTION: The exhaustive analysis of a marker for protein in blood leads to findings of markers of a major depressive disorder and a bipolar disorder. The findings allow inspection of a major depressive disorder and a bipolar disorder and screening of therapeutic medicines. The MICB and the PDGF-BB, in particular, can be highly efficient markers since they show significant differences between patients with a major depressive disorder or a bipolar disorder.;SELECTED DRAWING: Figure 1;COPYRIGHT: (C)2018,JPO&INPIT
机译:要解决的问题:提供针对重度抑郁症和双相情感障碍的标记物,检查方法和检查套件,以及针对重度抑郁症和双相情感障碍的治疗药物的筛选方法。对血液中蛋白质标记物的分析可发现重度抑郁症和双相情感障碍的标记物。这些发现可以检查主要的抑郁症和躁郁症,并筛选治疗药物。特别是MICB和PDGF-BB,由于在重度抑郁症或双相情感障碍患者之间显示出显着差异,因此可以成为高效的标记物。;部分抽签图:图1;版权:(C)2018,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号